Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro

NCT02104440 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytopenia

Interventions

BIOLOGICAL: Sequential infusion of allogeneic mesenchymal stem cells expanded "in vitro"

Sponsor

Red de Terapia Celular

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]